Osaic Holdings
VKTX icon

Osaic Holdings’s Viking Therapeutics VKTX Stock Holding History

Osaic Holdings’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-8
Closed -$1.75K – 8203
2025
Q3 		$1.75K Buy
8
+3
+60% +$89 ﹤0.01% 7172
2025
Q2 		$890 Sell
5
-16
-76% -$421 ﹤0.01% 7193
2025
Q1 		$19.2K Buy
21
+16
+320% +$506 ﹤0.01% 5393
2024
Q4 		$9.85K Buy
5
+3
+150% +$171 ﹤0.01% 5816
2024
Q3 		$10.6K Hold
2
– – ﹤0.01% 5785
2024
Q2 		$8.22K Hold
2
– – ﹤0.01% 5901
2024
Q1 		$14K Hold
2
– – ﹤0.01% 5559
2023
Q4 		$2.14K Hold
2
– – ﹤0.01% 6521
2023
Q3 		$860 Hold
2
– – ﹤0.01% 6867
2023
Q2 		$1.62K Buy
+2
New +$42 ﹤0.01% 6737

Other funds holding VKTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Osaic Holdings's VKTX Position: Q1 2026 in Review

Osaic Holdings increased its Viking Therapeutics (VKTX) stake by 29% in Q1 2026, buying an estimated $553K and bringing the position to 76,987 shares worth $2.51M. The position accounts for ﹤0.01% of the portfolio, ranked #1895.

Osaic Holdings first reported a position in VKTX in Q1 2020 and has held it in 25 quarters since. The position peaked at $2.54M in Q1 2024. 410 funds tracked by Wall St. Rank hold VKTX as of Q1 2026.

  • Osaic Holdings held 76,987 shares of Viking Therapeutics worth $2.51M as of Q1 2026.
  • Osaic Holdings bought 17,213 Viking Therapeutics shares in Q1 2026, an estimated $553K.
  • Viking Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #1895 holding.
  • Osaic Holdings first reported a position in Viking Therapeutics in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Viking Therapeutics position peaked at $2.54M in Q1 2024.
  • 410 funds tracked by Wall St. Rank held Viking Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.